MEASLES RUBEOLA ANTIBODIES PANEL IgG and IgM Test
Test Name: MEASLES RUBEOLA ANTIBODIES PANEL IgG and IgM Test
Components: IgG and IgM antibodies
Price: 700.0 AED
Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Report Delivery: Sample – Fri by 9 am; Report – Same day
Method: CLIA
Test Type: Infections
Doctor: Physician
Test Department:
Pre Test Information: No special preparation required
Test Details:
The Measles (Rubeola) Antibodies Panel IgG & IgM test is a blood test used to detect the presence of antibodies against the measles virus in the body. It measures both IgG and IgM antibodies, which are two types of antibodies produced by the immune system in response to an infection.
IgM antibodies are the first antibodies produced by the immune system during an active infection, and their presence indicates a recent or ongoing measles infection. IgG antibodies, on the other hand, are produced later in the infection and provide long-term immunity against the virus. Detecting IgG antibodies can indicate a past infection or previous vaccination.
This test is typically used to diagnose a current or recent measles infection, determine immunity status in individuals who may have been exposed to the virus, or assess the effectiveness of a measles vaccine. It is often performed in outbreak situations or in individuals with symptoms suggestive of measles, such as fever, rash, cough, and runny nose.
Interpretation of the test results depends on the levels of IgG and IgM antibodies detected. A positive IgM result with or without a positive IgG result indicates an active or recent infection. A positive IgG result with a negative IgM result suggests past infection or vaccination. A negative result for both IgG and IgM antibodies indicates no current or past infection and no immunity to the measles virus.
It is important to note that this test is not used for routine screening or diagnosis of measles, as clinical symptoms and history are usually sufficient for diagnosis. Additionally, false positive or false negative results can occur, so confirmatory testing may be required.
| Test Name | MEASLES RUBEOLA ANTIBODIES PANEL IgG and IgM Test |
|---|---|
| Components | |
| Price | 700.0 AED |
| Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. |
| Report Delivery | SampleFri by 9 am;ReportSameday |
| Method | CLIA |
| Test type | Infections |
| Doctor | Physician |
| Test Department: | |
| Pre Test Information | No special preparation required |
| Test Details | The Measles (Rubeola) Antibodies Panel IgG & IgM test is a blood test used to detect the presence of antibodies against the measles virus in the body. It measures both IgG and IgM antibodies, which are two types of antibodies produced by the immune system in response to an infection. IgM antibodies are the first antibodies produced by the immune system during an active infection, and their presence indicates a recent or ongoing measles infection. IgG antibodies, on the other hand, are produced later in the infection and provide long-term immunity against the virus. Detecting IgG antibodies can indicate a past infection or previous vaccination. This test is typically used to diagnose a current or recent measles infection, determine immunity status in individuals who may have been exposed to the virus, or assess the effectiveness of a measles vaccine. It is often performed in outbreak situations or in individuals with symptoms suggestive of measles, such as fever, rash, cough, and runny nose. Interpretation of the test results depends on the levels of IgG and IgM antibodies detected. A positive IgM result with or without a positive IgG result indicates an active or recent infection. A positive IgG result with a negative IgM result suggests past infection or vaccination. A negative result for both IgG and IgM antibodies indicates no current or past infection and no immunity to the measles virus. It is important to note that this test is not used for routine screening or diagnosis of measles, as clinical symptoms and history are usually sufficient for diagnosis. Additionally, false positive or false negative results can occur, so confirmatory testing may be required. |
